跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
安适利 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Brentuximab Vedotin for Injection
Approved
生物制品
Brentuximab Vedotin for Injection
Takeda Pharma A/S
🇨🇳 National Medical Products Administration
Approval Date
May 12, 2020
Approval ID
7yn0co33Mbs
Company
Takeda Pharma A/S
Type
生物制品
Approval Details
Approval Id
7yn0co33Mbs
Approval Number
S20200008
Generic Name
注射用维布妥昔单抗
Generic Name En
Brentuximab Vedotin for Injection
Trade Name
安适利
Drug Type
生物制品
Dosage Form
注射剂
Strength
50mg
Reg Date
2020-05-12
Expired Date
2025-05-11
Company Name
Takeda Pharma A/S
Company Address
Delta Park 45, 2665 Vallensbaek Strand, Denmark
Production Company Name
BSP PHARMACEUTICALS SPA
Production Company Address
Via Appia Km. 65,561, Latina Scalo (LT), 04013,Italy
Company Detail Path
/organization/takeda-pharma-a-s
Production Company Detail Path
/organization/bsp-pharmaceuticals-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 12, 2020
Approval ID
7yn0co33Mbs
Type
生物制品
Back to NMPA Approvals